KRTX

Karuna Therapeutics, Inc.

319.00 USD
+0.06 (+0.02%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Karuna Therapeutics, Inc. stock is up 1.22% since 30 days ago. The next earnings date is May 2, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 5 CALLs, 5 PUTs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
01 Feb 20:26 16 Feb, 2024 230.00 CALL 85 1574
02 Feb 16:58 15 Mar, 2024 280.00 PUT 1000 788
06 Feb 15:57 15 Mar, 2024 290.00 PUT 250 1208
06 Feb 16:04 17 May, 2024 300.00 PUT 73 200
06 Feb 16:30 16 Feb, 2024 250.00 CALL 4 37
06 Feb 16:55 17 May, 2024 300.00 PUT 50 200
12 Feb 20:54 17 Jan, 2025 200.00 CALL 3 10
14 Feb 15:10 16 Feb, 2024 250.00 CALL 5 37
15 Feb 17:37 16 Feb, 2024 250.00 CALL 5 37
16 Feb 19:10 15 Mar, 2024 310.00 PUT 100 589

About Karuna Therapeutics, Inc.

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia.

  • Cantor Fitzgerald
    Tue Feb 20, 12:37
    hold
    confirm
  • Mizuho
    Fri Jan 26, 05:57
    hold
    downgrade